Michael has served on the Board of Directors and as Treasurer of MassBioEd since June 2019. Separately, he is the Corporate Controller at Triplet Therapeutics, a private clinical-stage company focused on developing treatments for repeat expansion disorders, including Huntington’s, myotonic dystrophy, and spinocerebellar ataxias, among others. Before joining Triplet Therapeutics in early 2021, he worked as an Assurance Senior Manager in Ernst & Young LLP’s Life Sciences Practice in Cambridge, MA through 2020. With over 10 years of experience, he assisted clients in the life sciences industry with various accounting and auditing matters. Finally, he received his Bachelor of Science in Business Administration from Boston University and is a member of the American Institute of Certified Public Accountants, as well as the Massachusetts Society of Certified Public Accountants.